WallStreetZenWallStreetZen

NASDAQ: ADXN
Addex Therapeutics Ltd Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ADXN past revenue growth

How has ADXN's revenue growth performed historically?
Company
-26.19%
Industry
69.54%
Market
14.01%
ADXN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ADXN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

ADXN earnings and revenue history

Current Revenue
$1.9M
Current Earnings
-$19.1M
Current Profit Margin
-1,031.2%

ADXN Return on Equity

Current Company
-292.3%
Current Industry
-18%
Current Market
30.8%
ADXN's Return on Equity (-292.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ADXN announces earnings.

ADXN Return on Assets

Current Company
-177.4%
Current Industry
0.9%
ADXN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ADXN Return on Capital Employed

Current Company
-416.41%
Current Industry
14.1%
ADXN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ADXN vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ADXN$1.89M-$18.87M-$19.54M-73.70%N/A
XCUR$28.83M$78.00k-$2.58M+24.29%N/A
ZVSA$0.00-$17.48M-$26.89MN/AN/A
WINT$0.00-$35.95M-$35.19M-100.00%N/A
DFFN$0.00-$15.16M-$15.16MN/AN/A
View Top Biotech Stocks

Addex Therapeutics Earnings & Revenue FAQ

What were ADXN's earnings last quarter?

On Invalid Date, Addex Therapeutics (NASDAQ: ADXN) reported Q1 2023 earnings per share (EPS) of -$0.04, up 73.01% year over year. Total Addex Therapeutics earnings for the quarter were -$2.65 million. In the same quarter last year, Addex Therapeutics's earnings per share (EPS) was -$0.16.

If you're new to stock investing, here's how to buy Addex Therapeutics stock.

What was ADXN's earnings growth in the past year?

As of Q2 2023, Addex Therapeutics's earnings has grown year over year. Addex Therapeutics's earnings in the past year totalled -$19.54 million.

What was ADXN's revenue last quarter?

On Invalid Date, Addex Therapeutics (NASDAQ: ADXN) reported Q1 2023 revenue of $550.43 thousand up 113.46% year over year. In the same quarter last year, Addex Therapeutics's revenue was $257.87 thousand.

What was ADXN's revenue growth in the past year?

As of Q2 2023, Addex Therapeutics's revenue has grown -26.19% year over year. This is 95.72 percentage points lower than the US Biotechnology industry revenue growth rate of 69.54%. Addex Therapeutics's revenue in the past year totalled $1.89 million.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.